{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:09:36Z","timestamp":1760954976806},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1007\/s11940-003-0014-z","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T19:05:37Z","timestamp":1180983937000},"page":"231-239","source":"Crossref","is-referenced-by-count":18,"title":["Sleepiness and unintended sleep in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"5","author":[{"given":"David B.","family":"Rye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","first-page":"687","volume-title":"Movement Disorders: Neurologic Principles and Practice","author":"D Rye","year":"1997","unstructured":"Rye D, Bliwise D: Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In Movement Disorders: Neurologic Principles and Practice. Edited by Watts R, Koller W. New York: McGraw-Hill, Inc.; 1997:687\u2013713."},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2869.2000.00201.x","volume":"9","author":"DB Rye","year":"2000","unstructured":"Rye DB, Bliwise DL, Dihenia B, Gurecki P: FAST TRACK: daytime sleepiness in Parkinson\u2019s disease. J Sleep Res 2000, 9:63\u201369. A good article.","journal-title":"J Sleep Res"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.58.3.341","volume":"58","author":"DB Rye","year":"2002","unstructured":"Rye DB, Jankovic J: Emerging views of dopamine in modulating sleep\/wake state from an unlikely source: PD. Neurology 2002, 58:341\u2013346. An excellent review.","journal-title":"Neurology"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.52.9.1908","volume":"52","author":"S Frucht","year":"1999","unstructured":"Frucht S, Rogers J, Greene P, et al.: Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999, 52:1908\u20131910.","journal-title":"Neurology"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.57.8.1392","volume":"57","author":"WG Ondo","year":"2001","unstructured":"Ondo WG, Vuong KV, Khan H, et al.: Daytime sleepiness and other sleep disorders in Parkinson\u2019s disease. Neurology 2001, 57:1392\u20131396.","journal-title":"Neurology"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1353-8020(00)00076-6","volume":"7","author":"CC Sanjiv","year":"2001","unstructured":"Sanjiv CC, Schulzer M, Mak E, et al.: Daytime somnolence in patients with Parkinson\u2019s disease. Park Rel Disord 2001, 7:283\u2013286.","journal-title":"Park Rel Disord"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archneur.59.6.986","volume":"59","author":"PE O\u2019Suilleabhain","year":"2002","unstructured":"O\u2019Suilleabhain PE, Dewey RB: Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol 2002, 59:986\u2013989.","journal-title":"Arch Neurol"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","volume":"287","author":"DE Hobson","year":"2002","unstructured":"Hobson DE, Lang AE, Martin WRW, et al.: Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. JAMA 2002, 287:455\u2013463.","journal-title":"JAMA"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7","volume":"14","author":"E Tandberg","year":"1999","unstructured":"Tandberg E, Larsen J, Karlsen K: Excessive daytime sleepiness and sleep benefit in Parkinson\u2019s disease: a community based study. Mov Disord 1999, 14:922\u2013927.","journal-title":"Mov Disord"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.58.3.465","volume":"58","author":"EK Tan","year":"2002","unstructured":"Tan EK, Lum SY, Fook-Chong SMC, et al.: Evaluation of somnolence in Parkinson\u2019s disease: comparison with age and sex matched controls. Neurology 2002, 58:465\u2013468.","journal-title":"Neurology"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/WNL.58.10.1544","volume":"58","author":"MD Gjerstad","year":"2002","unstructured":"Gjerstad MD, Aarsland D, Larsen JP: Development of daytime somnolence over time in Parkinson\u2019s disease. Neurology 2002, 58:1544\u20131546.","journal-title":"Neurology"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002826-200105000-00013","volume":"24","author":"J-L Montastruc","year":"2001","unstructured":"Montastruc J-L, Brefel-Courbon C, Senard J-M, et al.: Sleep attacks and anti-parkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clin Neuropharmacol 2001, 24:181\u2013183.","journal-title":"Clin Neuropharmacol"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.10167","volume":"17","author":"S Kumar","year":"2002","unstructured":"Kumar S, Bhatia M, Behari M: Sleep disorders in Parkinson\u2019s disease. Mov Disord 2002, 17:775\u2013781.","journal-title":"Mov Disord"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","volume":"58","author":"I Arnulf","year":"2002","unstructured":"Arnulf I, Konofal E, Merino-Andreu M, et al.: Clinical profiles of somnolence in Parkinson\u2019s disease. Neurology 2002, 58:1019\u20131024.","journal-title":"Neurology"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/0140-6736(91)92989-F","volume":"337","author":"Y Agid","year":"1991","unstructured":"Agid Y: Parkinson\u2019s disease: pathophysiology. Lancet 1991, 337:1321\u20131324.","journal-title":"Lancet"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.53.8.1868","volume":"53","author":"D Rye","year":"1999","unstructured":"Rye D, Johnston L, Watts R, Bliwise D: Juvenile Parkinson\u2019s disease with REM behavior disorder, sleepiness and daytime REM-onsets. Neurology 1999, 53:1868\u20131870.","journal-title":"Neurology"},{"key":"14_CR17","first-page":"1514","volume":"26","author":"M Decker","year":"2000","unstructured":"Decker M, Keating G, Freeman A, Rye D: Parkinsonianlike sleep-wake architecture in rats with bilateral striatal 6-OHDA lesions. Soc Neurosci Abstracts 2000, 26:1514.","journal-title":"Soc Neurosci Abstracts"},{"issue":"suppl","key":"14_CR18","first-page":"S218","volume":"22","author":"J Daley","year":"1999","unstructured":"Daley J, Turner R, Bliwise D, Rye D: Nocturnal sleep and daytime alertness in the MPTP-treated primate. Sleep 1999, 22(suppl):S218-S219.","journal-title":"Sleep"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1212\/WNL.56.12.1616","volume":"56","author":"MH Silber","year":"2001","unstructured":"Silber MH, Rye DB: Solving the mysteries of narcolepsy. Neurology 2001, 56:1616\u20131618.","journal-title":"Neurology"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1476-5381.1988.tb11715.x","volume":"95","author":"G Bagetta","year":"1988","unstructured":"Bagetta G, Sarro GD, Priolo E, Nistic\u00f3 G: Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioral and electrocortical sleep in rats. Br J Pharmacol 1988, 95:860\u2013866.","journal-title":"Br J Pharmacol"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0306-4522(99)00271-7","volume":"93","author":"C Berridge","year":"1999","unstructured":"Berridge C, O\u2019Neil J, Wifler K: Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience 1999, 93:885\u2013896.","journal-title":"Neuroscience"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","volume":"14","author":"K Jellinger","year":"1991","unstructured":"Jellinger K: Pathology of Parkinson\u2019s disease: changes other than the nigrostriatal pathway. Mol Chem Neuropathol 1991, 14:153\u2013197.","journal-title":"Mol Chem Neuropathol"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/sleep\/20.9.757","volume":"20","author":"D Rye","year":"1997","unstructured":"Rye D: Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997, 20:757\u2013788.","journal-title":"Sleep"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.47.6.1403","volume":"47","author":"M Mega","year":"1996","unstructured":"Mega M, Masterman D, Benson F, et al.: Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996, 47:1403\u20131409.","journal-title":"Neurology"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1212\/WNL.46.2.388","volume":"46","author":"C Schenck","year":"1996","unstructured":"Schenck C, Bundlie S, Mahowald M: Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996, 46:388\u2013393.","journal-title":"Neurology"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1212\/WNL.54.1.274","volume":"54","author":"S Frucht","year":"2000","unstructured":"Frucht S, Rogers J, Greene P, et al.: Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole [letters to the editor]. Neurology 2000, 54:274\u2013277.","journal-title":"Neurology"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/1531-8257(200003)15:2<212::AID-MDS1002>3.0.CO;2-6","volume":"15","author":"CW Olanow","year":"2000","unstructured":"Olanow CW, Schapira AHV, Roth T: Waking up to sleep episodes in Parkinson\u2019s disease. Mov Disord 2000, 15:212\u2013215.","journal-title":"Mov Disord"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1592\/phco.20.7.724.35181","volume":"20","author":"M Ryan","year":"2000","unstructured":"Ryan M, Slevin J, Wells A: Non-ergot dopamine agonist-induced sleep attacks. Pharmacotherapy 2000, 20:724\u2013726.","journal-title":"Pharmacotherapy"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N","volume":"15","author":"R Hauser","year":"2000","unstructured":"Hauser R, Gauaer L, Anderson W, Zesiewicz T: Pramipexoleinduced somnolence and episodes of daytime sleep. Mov Disord 2000, 15:658\u2013663.","journal-title":"Mov Disord"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(00)02119-X","volume":"355","author":"J Ferreira","year":"2000","unstructured":"Ferreira J, Galitzky M, Montastruc J, Rascol O: Sleep attacks and Parkinson\u2019s disease treatment. Lancet 2000, 355:1333\u20131334.","journal-title":"Lancet"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.1083","volume":"16","author":"F Tracik","year":"2001","unstructured":"Tracik F, Ebersbach G: Sudden daytime sleep onset in Parkinson\u2019s disease: polysomnographic recordings. Mov Disord 2001, 16:500\u2013506.","journal-title":"Mov Disord"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1212\/WNL.58.3.462","volume":"58","author":"M Ulivelli","year":"2002","unstructured":"Ulivelli M, Rossi S, Lombard C, et al.: Polysomnographic characterization of pergolide-induced \u201csleep attacks\u201d in an idiopathic PD patient. Neurology 2002, 58:462\u2013465.","journal-title":"Neurology"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00002826-199901000-00004","volume":"22","author":"N Andreau","year":"1999","unstructured":"Andreau N, Chale J, Senard J, et al.: L-dopa induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. Clin Neuropharmacol 1999, 22:15\u201323.","journal-title":"Clin Neuropharmacol"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1212\/WNL.58.3.460","volume":"58","author":"JJ Ferreira","year":"2002","unstructured":"Ferreira JJ, Galitzky M, Thalamas C, et al.: Effect of ropinirole on sleep onset: a randomized placebo controlled study in healthy volunteers. Neurology 2002, 58:460\u2013462.","journal-title":"Neurology"},{"key":"14_CR35","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1164\/ajrccm.163.7.2103055e","volume":"163","author":"DL Bliwise","year":"2001","unstructured":"Bliwise DL: Is the measurement of sleepiness the Holy Grail of sleep medicine? Am J Resp Crit Care Med 2001, 163:1517\u20131519.","journal-title":"Am J Resp Crit Care Med"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"M Johns","year":"1991","unstructured":"Johns M: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991, 14:540\u2013545.","journal-title":"Sleep"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/mds.10193","volume":"17","author":"G Fabbrini","year":"2002","unstructured":"Fabbrini G, Barbanti P, Aurilia C, et al.: Excessive daytime sleepiness in de novo and treated Parkinson\u2019s disease. Mov Disord 2002, 17:1026\u20131030.","journal-title":"Mov Disord"},{"key":"14_CR38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.10020","volume":"17","author":"JC Moller","year":"2002","unstructured":"Moller JC, Stiasny K, Hargutt V, et al.: Evaluation of sleep and driving performance in six patients with Parkinson\u2019s disease reporting sudden onset of sleep under dopaminergic medication: a pilot study. Mov Disord 2002, 17:474\u2013481.","journal-title":"Mov Disord"},{"key":"14_CR39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/sleep\/20.8.608","volume":"20","author":"T Young","year":"1997","unstructured":"Young T, Blustein J, Finn L, Palta M: Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997, 20:608\u2013613.","journal-title":"Sleep"},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/1531-8257(200011)15:6<1269::AID-MDS1036>3.0.CO;2-R","volume":"15","author":"RA Hauser","year":"2000","unstructured":"Hauser RA, Wahba MN, Anderson WM: Modafinil treatment of pramipexole-associated somnolence. Mov Disord 2000, 15:1269\u20131271.","journal-title":"Mov Disord"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1353-8020(00)00035-3","volume":"7","author":"A Rabinstein","year":"2001","unstructured":"Rabinstein A, Shulman LM, Weiner WJ: Modafinil for the treatment of excessive daytime sleepiness in Parkinson\u2019s disease: a case report. Park Rel Disord 2001, 7:287\u2013288.","journal-title":"Park Rel Disord"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00002826-200203000-00010","volume":"25","author":"AV Nieves","year":"2002","unstructured":"Nieves AV, Lang AE: Treatment off excessive daytime sleepiness in patients with Parkinson\u2019s disease with modafinil. Clin Neuropharmacol 2002, 25:111\u2013114.","journal-title":"Clin Neuropharmacol"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/npp.1994.43","volume":"11","author":"B Cooper","year":"1994","unstructured":"Cooper B, Wang C, Cox R, et al.: Evidence that the acute behavioral and electrophysiological effects of bupropion are mediated by a noradrenergic mechanism. Neuropsychopharmacology 1994, 11:133\u2013141.","journal-title":"Neuropsychopharmacology"},{"key":"14_CR44","first-page":"2657","volume":"73","author":"E Miller","year":"1973","unstructured":"Miller E, Nieburg H: Amphetamines: valuable adjunct in treatment of Parkinsonism. N Y State J Med 1973, 73:2657\u20132661.","journal-title":"N Y State J Med"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jnnp.38.3.232","volume":"38","author":"JD Parkes","year":"1975","unstructured":"Parkes JD, Tarsy D, Marsden CD, et al.: Amphetamines in the treatment of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 1975, 38:232\u2013237.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.50.5.1332","volume":"50","author":"BE Hogl","year":"1998","unstructured":"Hogl BE, Gomez-Arevalo G, Garcia S, et al.: A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson\u2019s disease. Neurology 1998, 50:1332\u20131339.","journal-title":"Neurology"},{"key":"14_CR47","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","volume":"21","author":"J Wisor","year":"2001","unstructured":"Wisor J, Nishino S, Sora I, et al.: Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001, 21:1787\u20131794.","journal-title":"J Neurosci"},{"key":"14_CR48","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s002210000370","volume":"133","author":"P Jenner","year":"2000","unstructured":"Jenner P, Zeng BY, Smith LA, et al.: Antiparkinsonian and neuroprotective effects of modafinil in the MPTPtreated common marmoset. Exp Brain Res 2000, 133:178\u2013188.","journal-title":"Exp Brain Res"},{"key":"14_CR49","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/(SICI)1520-6394(1998)7:2<92::AID-DA9>3.0.CO;2-7","volume":"7","author":"D Rye","year":"1998","unstructured":"Rye D, Dihenia B, Bliwise D: Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion. Depress Anxiety 1998, 7:92\u201395. A good article.","journal-title":"Depress Anxiety"},{"key":"14_CR50","first-page":"127","volume":"215","author":"BR Cooper","year":"1980","unstructured":"Cooper BR, Hester TJ, Maxwell RA: Behavioral and biochemical effects of the antidepressant bupropion: evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 1980, 215:127\u2013134.","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR51","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.34.8.1092","volume":"34","author":"C Goetz","year":"1984","unstructured":"Goetz C, Tanner C, Klawans H: Bupropion for Parkinson\u2019s disease. Neurology 1984, 34:1092\u20131094.","journal-title":"Neurology"},{"key":"14_CR52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.102.039743","volume":"303","author":"M Hansard","year":"2002","unstructured":"Hansard M, Smith L, Jackson M, et al.: Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated primates. J Pharmacol Exp Ther 2002, 303:952\u2013958.","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR53","first-page":"395","volume":"56","author":"J Ascher","year":"1995","unstructured":"Ascher J, Cole J, Colin J-N, et al.: Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995, 56:395\u2013401.","journal-title":"J Clin Psychiatry"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.55.11.1732","volume":"55","author":"I Arnulf","year":"2000","unstructured":"Arnulf I, Bejjani B, Garma L, et al.: Improvement of sleep architecture in PD with subthalamic nucleus stimulation. Neurology 2000, 55:1732\u20131734.","journal-title":"Neurology"},{"key":"14_CR55","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.72.5.661","volume":"72","author":"A Iranzo","year":"2002","unstructured":"Iranzo A, Valldeoriola F, Santamaria J, et al.: Sleep symptoms and polysomnographic architecture in advanced Parkinson\u2019s disease after chronic bilateral subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002, 72:661\u2013664.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"14_CR56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000050756","volume":"46","author":"L Lopiano","year":"2001","unstructured":"Lopiano L, Rizzone M, Bergamasco B, et al.: Daytime sleepiness improvement following bilateral chronic electrical stimulation of the subthalamic nucleus in Parkinson\u2019s disease. Eur Neurol 2001, 46:49\u201350.","journal-title":"Eur Neurol"},{"key":"14_CR57","first-page":"591","volume":"26","author":"D Rye","year":"1997","unstructured":"Rye D, Dempsay J, Dihenia B, et al.: REM-sleep dyscontrol in Parkinson\u2019s disease: case report of effects of elective pallidotomy. Sleep Res 1997, 26:591.","journal-title":"Sleep Res"},{"key":"14_CR58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mds.870120608","volume":"12","author":"KR Chaudhuri","year":"1997","unstructured":"Chaudhuri KR, Ellis C, Love-Jones S, et al.: Postprandial hypotension and parkinsonian state in Parkinson\u2019s disease. Mov Disord 1997, 12:877\u2013884.","journal-title":"Mov Disord"},{"key":"14_CR59","first-page":"R396","volume":"254","author":"N Alexander","year":"1988","unstructured":"Alexander N, Nakahara D, Ozaki N, et al.: Striatal dopamine release and metabolism in sinoaorticdenervated rats by in vivo microdialysis. Am J Physiol 1988, 254:R396\u2013399.","journal-title":"Am J Physiol"},{"key":"14_CR60","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0304-3940(93)90633-V","volume":"157","author":"JJ Yang","year":"1993","unstructured":"Yang JJ, Lin MT: Arterial baroreceptor information affects striatal dopamine release measured by voltammetry in rats. Neurosci Lett 1993, 157:21\u201324.","journal-title":"Neurosci Lett"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-003-0014-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-003-0014-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-003-0014-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:46Z","timestamp":1559437006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-003-0014-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11940-003-0014-z","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}